<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2023-4-42-49</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1458</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Дистрофическая кальцифилаксия при панникулите: особенности клинической картины и диагностики</article-title><trans-title-group xml:lang="en"><trans-title>Dystrophic calciphylaxis in panniculitis: features of the clinical picture and diagnosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4846-5531</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Егорова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Egorova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Егорова Ольга Николаевна.</p><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>Olga N. Egorova.</p><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><email xlink:type="simple">onegorova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3051-219X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дацина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Datsina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>1, Ostrovitianov Street, Moscow 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3444-7682</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Северинова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Severinova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>08</month><year>2023</year></pub-date><volume>17</volume><issue>4</issue><fpage>42</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Егорова О.Н., Дацина А.В., Северинова М.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Егорова О.Н., Дацина А.В., Северинова М.В.</copyright-holder><copyright-holder xml:lang="en">Egorova O.N., Datsina A.V., Severinova M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1458">https://mrj.ima-press.net/mrj/article/view/1458</self-uri><abstract><p>Клиническая картина лобулярного панникулита (Пн), ассоциированного с кальцифилаксией (КФ, кальциноз), может широко варьироваться, сопровождаясь поражением суставов и внутренних органов, что затрудняет диагностику заболевания.</p><p>Цель исследования — на основании многолетнего проспективного наблюдения оценить частоту развития и значение КФ у пациентов с Пн.</p><sec><title>Материал и методы</title><p>Материал и методы. С 2018 по 2023 г. в ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой» обследовано 217 пациентов с направительными диагнозами «узловатая эритема» или «панникулит». В 19,3% случаев (9 мужчин и 33 женщины в возрасте 37—72 лет) подтверждена КФ со средней длительностью заболевания 56,3±11,2 мес. Клиническое обследование больных проводили по стандартам, рекомендованным Ассоциацией ревматологов России. Для подтверждения диагноза системной красной волчанки (СКВ), идиопатических воспалительных миопатий (ИВМ), системного склероза (СС) и липодерматосклероза (ЛДС) использовали международные критерии. У 12 больных с уплотнениями осуществлялось патоморфологическое исследование биоптатов кожи и подкожной жировой клетчатки из области уплотнения, позволившее верифицировать диагноз идиопатического лобулярного Пн (ИЛПн) в 3 случаях.</p><p>Выделены четыре степени кальциноза в зависимости от размера и глубины расположения кальцинатов. Кроме того, с учетом характера рентгенологических изменений и клинических проявлений определено четыре подтипа КФ: муссовый, каменный, сетчатый и пластинчатый.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. В исследуемой группе соотношение женщин и мужчин составило 3,6:1, средний возраст — 43,8±7,6 года. При клиническом обследовании в 60% случаев определялась КФ преимущественно каменного подтипа (71,4%) 1-й степени (47,6%), которая значимо чаще локализовалась на верхних и/или нижних конечностях и/или туловище (57,1%; р=0,05). Клинические и лабораторно-инструментальные данные позволили подтвердить развитие КФ при ИЛПн (n=3), СКВ (n=3), ЛДС (n=21), ИВМ (n=5), СС (n=1), а также идиопатическую КФ (n=9) со средней длительностью заболеваний 8,7±2,4 года.</p><p>Повышение СОЭ и уровня СРБ встречалось при разных нозологиях, в то время как мочевой синдром ассоциировался с СКВ (66,6%), а увеличение уровня креатининфосфокиназы — с ИВМ. Пониженный уровень кальция и 25-гидроксивитамина D, а также повышенное содержание фосфора и паратиреоидного гормона выявлены у многих обследованных.</p></sec><sec><title>Заключение</title><p>Заключение. Учитывая отсутствие четких диагностических критериев КФ у больных Пн, ранняя диагностика имеет решающее значение для разработки эффективного плана мультидисциплинарного лечения.</p></sec></abstract><trans-abstract xml:lang="en"><p>The clinical presentation of lobular panniculitis (PN) associated with calciphylaxis (CP, calcification) can vary widely and may be associated with joint and internal organs involvement, making the diagnosis of the disease difficult.</p><sec><title>Objective</title><p>Objective: to evaluate the frequency and significance of CP in patients with PN using long-term prospective follow-up.</p></sec><sec><title>Material and methods</title><p>Material and methods. From 2018 to 2023, at the V.A. Nasonova Research Institute of Rheumatology 217 patients with referral diagnosis "erythema nodosum" or "panniculitis" were examined. In 19.3% of cases (9 men and 33 women aged 37 to 72 years) CP was confirmed with an average disease duration of 56.3±11.2 months. Clinical examination of patients was performed according to the standards recommended by the Russian Association of Rheumatologists. International criteria were used to confirm the diagnosis of systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), systemic sclerosis (SS), and lipodermatosclerosis (LDS). In 12 patients with indurations, pathological examination of biopsy specimens of skin and subcutaneous fatty tissue from the area of induration was performed, which allowed confirming the diagnosis of idiopathic lobular PN (ILPN) in 3 cases. </p><p>Four grades of calcification were distinguished according to the size and depth of the calcifications. In addition, considering the type of radiological changes and clinical manifestations, four subtypes of CP were identified: mousse-like, stone-like, mesh-like and lamellar-like.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. In the study group, the ratio of women to men was 3.6:1, and the mean age was 43.8±7.6 years. On clinical examination we determined, in 60% of cases CP predominantly stone-like subtype (71.4%) of first grade (47.6%), which was significantly more frequently located on the upper and/or lower extremities and/or trunk (57.1%; p=0.05). Using clinical, laboratory and instrumental data, we confirmed the development of CP in ILPN (n=3), SLE (n=3), LDS (n=21), IIM (n=5), SS (n=1), and idiopathic CP (n=9) with a mean disease duration of 8.7±2.4 years.</p><p>An increase in ESR and CRP levels occurred in different diseases, while urinary syndrome was associated with SLE (66.6%) and an increase in creatinine phosphokinase with IIM. Decreased calcium and 25-hydroxyvitamin D levels and increased phosphorus and parathyroid hormone levels were found in many patients studied.</p></sec><sec><title>Conclusion</title><p>Conclusion. In the absence of clear diagnostic criteria for CP in patients with PN, early diagnosis is critical for the development of an effective multidisciplinary treatment plan.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>лобулярный панникулит</kwd><kwd>кальцифилаксия</kwd><kwd>кальциноз мягких тканей</kwd><kwd>диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lobular panniculitis</kwd><kwd>calciphylaxis</kwd><kwd>soft tissue calcification</kwd><kwd>diagnosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена в рамках научно-исследовательской работы, № государственных заданий 1021051402790-6.</funding-statement><funding-statement xml:lang="en">The article has been conducted within scientific topic № 1021051402790-6 as a part of the government task.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Llamas-Velasco M, Fraga J, Sanchez-Schmidt JM, et al. Neutrophilic Infiltrates in Panniculitis: Comprehensive Review and Diagnostic Algorithm Proposal. Am J Dermatopathol. 2020 Oct;42(10):717-730. doi: 10.1097/DAD.0000000000001597.</mixed-citation><mixed-citation xml:lang="en">Llamas-Velasco M, Fraga J, Sanchez-Schmidt JM, et al. Neutrophilic Infiltrates in Panniculitis: Comprehensive Review and Diagnostic Algorithm Proposal. Am J Dermatopathol. 2020 Oct;42(10):717-730. doi: 10.1097/DAD.0000000000001597.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Егорова ОН, Белов БС, Глухова СИ, Раденска-Лоповок СГ. Панникулит в современной ревматологии. Терапевтический архив. 2020;92(5):33-38.</mixed-citation><mixed-citation xml:lang="en">Egorova ON, Belov BS, Glukhova SI, Radenska-Lopovok SG. Panniculitis in modern rheumatology. Terapevticheskii arkhiv. 2020; 92(5):33-38. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zoller ES , Rizzo М, Harris A.Understanding calcinosis cutis. JAAPA. 2020 Nov;33(11): 25-28. doi: 10.1097/01.JAA.0000718276.11292.e2.</mixed-citation><mixed-citation xml:lang="en">Zoller ES , Rizzo М, Harris A.Understanding calcinosis cutis. JAAPA. 2020 Nov;33(11): 25-28. doi: 10.1097/01.JAA.0000718276.11292.e2.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Traineau Н, Aggarwal R, Monfort JB, et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature. J Am Acad Dermatol. 2020 Feb;82(2): 317-325. doi: 10.1016/j.jaad.2019.07.006.</mixed-citation><mixed-citation xml:lang="en">Traineau Н, Aggarwal R, Monfort JB, et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature. J Am Acad Dermatol. 2020 Feb;82(2): 317-325. doi: 10.1016/j.jaad.2019.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Le С, Bedocs РМ. Calcinosis Cutis. Stat-Pearls Publishing; 2023.</mixed-citation><mixed-citation xml:lang="en">Le С, Bedocs РМ. Calcinosis Cutis. Stat-Pearls Publishing; 2023.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bryant J, White W. A case of calcification of the arteries and obloterative endarterities, associated with hydronephrosis, in a child aged six months. Guys Hosp Rep. 1898;55:17-20.</mixed-citation><mixed-citation xml:lang="en">Bryant J, White W. A case of calcification of the arteries and obloterative endarterities, associated with hydronephrosis, in a child aged six months. Guys Hosp Rep. 1898;55:17-20.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology. 1962 Oct;71: 554-8. doi: 10.1210/endo-71-4-554.</mixed-citation><mixed-citation xml:lang="en">Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology. 1962 Oct;71: 554-8. doi: 10.1210/endo-71-4-554.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sowers K, Hayden M. Calcific uremic arteriopathy: Pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354.</mixed-citation><mixed-citation xml:lang="en">Sowers K, Hayden M. Calcific uremic arteriopathy: Pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Baby D, Upadhyay M, Joseph MD, et al. Calciphylaxis and its diagnosis: a review. J Family Med Prim Care. 2019 Sep 30;8(9): 2763-2767. doi: 10.4103/jfmpc.jfmpc58819.</mixed-citation><mixed-citation xml:lang="en">Baby D, Upadhyay M, Joseph MD, et al. Calciphylaxis and its diagnosis: a review. J Family Med Prim Care. 2019 Sep 30;8(9): 2763-2767. doi: 10.4103/jfmpc.jfmpc58819.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Elahmar Н, Feldman ВМ, Johnson SR. Management of Calcinosis Cutis in Rheumatic Diseases. J Rheumatol. 2022 Sep;49(9): 980-989. doi: 10.3899/jrheum.211393. Epub 2022 May 15.</mixed-citation><mixed-citation xml:lang="en">Elahmar Н, Feldman ВМ, Johnson SR. Management of Calcinosis Cutis in Rheumatic Diseases. J Rheumatol. 2022 Sep;49(9): 980-989. doi: 10.3899/jrheum.211393. Epub 2022 May 15.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gutierrez A Jr, Wetter DA. Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther. 2012 Mar-Apr;25(2):195-206. doi: 10.1111/j.1529-8019.2012.01492.x.</mixed-citation><mixed-citation xml:lang="en">Gutierrez A Jr, Wetter DA. Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther. 2012 Mar-Apr;25(2):195-206. doi: 10.1111/j.1529-8019.2012.01492.x.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Davuluri S, Lood C, Chung L. Calcinosis in systemic sclerosis. Curr Opin Rheumatol. 2022 Nov 1;34(6):319-327. doi: 10.1097/BOR.0000000000000896. Epub 2022 Aug 19.</mixed-citation><mixed-citation xml:lang="en">Davuluri S, Lood C, Chung L. Calcinosis in systemic sclerosis. Curr Opin Rheumatol. 2022 Nov 1;34(6):319-327. doi: 10.1097/BOR.0000000000000896. Epub 2022 Aug 19.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Антелава ОА, Егорова ОН, Белов БС и др. Панникулит при дерматомиозите. Научно-практическая ревматология. 2016;54(2):227-232.</mixed-citation><mixed-citation xml:lang="en">Antelava OA, Egorova ON, Belov BS, et al. Panniculitis in dermatomyositis. Nauchno-prakticheskaya revmatologiya. 2016;54(2): 227-232. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gauhar R, Wilkinson J, Harris J, et al. Calcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis. Scand J Rheumatol. 2016 Jul;45(4):317-20. doi: 10.3109/03009742.2015.1127412. Epub 2016 Jan 26.</mixed-citation><mixed-citation xml:lang="en">Gauhar R, Wilkinson J, Harris J, et al. Calcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis. Scand J Rheumatol. 2016 Jul;45(4):317-20. doi: 10.3109/03009742.2015.1127412. Epub 2016 Jan 26.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz-Dominguez MP, Garcia-Collinot G, Saavedra MA, et al. Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol. 2017 Jan; 36(1):111-117. doi: 10.1007/s10067-016-3412-9. Epub 2016 Oct 7.</mixed-citation><mixed-citation xml:lang="en">Cruz-Dominguez MP, Garcia-Collinot G, Saavedra MA, et al. Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol. 2017 Jan; 36(1):111-117. doi: 10.1007/s10067-016-3412-9. Epub 2016 Oct 7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005 Jun;34(6):805-12. doi: 10.1016/j.semarthrit.2005.01.016.</mixed-citation><mixed-citation xml:lang="en">Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005 Jun;34(6):805-12. doi: 10.1016/j.semarthrit.2005.01.016.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Al Mehmadi BA, To FZ, Anderson MA, Johnson SR. Epidemiology and treatment of peripheral neuropathy in systemic sclerosis. J Rheumatol. 2021 Dec;48(12):1839-1849. doi: 10.3899/jrheum.201299. Epub 2021 Jul 1.</mixed-citation><mixed-citation xml:lang="en">Al Mehmadi BA, To FZ, Anderson MA, Johnson SR. Epidemiology and treatment of peripheral neuropathy in systemic sclerosis. J Rheumatol. 2021 Dec;48(12):1839-1849. doi: 10.3899/jrheum.201299. Epub 2021 Jul 1.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pai S, Hsu V. Are there risk factors for scleroderma-related calcinosis? Mod Rheumatol. 2018 May;28(3):518-522. doi: 10.1080/14397595.2017.1349594. Epub 2017 Jul 19.</mixed-citation><mixed-citation xml:lang="en">Pai S, Hsu V. Are there risk factors for scleroderma-related calcinosis? Mod Rheumatol. 2018 May;28(3):518-522. doi: 10.1080/14397595.2017.1349594. Epub 2017 Jul 19.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ferri C, Valentini G, Cozzi F et al; Syste-mic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002 Mar;81(2): 139-53. doi: 10.1097/00005792-200203000-00004.</mixed-citation><mixed-citation xml:lang="en">Ferri C, Valentini G, Cozzi F et al; Syste-mic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002 Mar;81(2): 139-53. doi: 10.1097/00005792-200203000-00004.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Avouac J, Mogavero G, Guerini H, et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis. 2011 Apr;70(4):630-3. doi: 10.1136/ard.2010.134304. Epub 2010 Dec 3.</mixed-citation><mixed-citation xml:lang="en">Avouac J, Mogavero G, Guerini H, et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis. 2011 Apr;70(4):630-3. doi: 10.1136/ard.2010.134304. Epub 2010 Dec 3.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mierau R, Moinzadeh P, Riemekasten G, et al. Frequency of disease-associated and ot-her nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21.</mixed-citation><mixed-citation xml:lang="en">Mierau R, Moinzadeh P, Riemekasten G, et al. Frequency of disease-associated and ot-her nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984 Feb;27(2):125-31. doi: 10.1002/art.1780270202.</mixed-citation><mixed-citation xml:lang="en">Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984 Feb;27(2):125-31. doi: 10.1002/art.1780270202.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Baron M, Pope J, Robinson D, et al. Calcinosis is associated with digital ischaemia in systemic sclerosisa longitudinal study. Rheumatology (Oxford). 2016 Dec;55(12):2148-2155. doi: 10.1093/rheumatology/kew313. Epub 2016 Sep 4.</mixed-citation><mixed-citation xml:lang="en">Baron M, Pope J, Robinson D, et al. Calcinosis is associated with digital ischaemia in systemic sclerosisa longitudinal study. Rheumatology (Oxford). 2016 Dec;55(12):2148-2155. doi: 10.1093/rheumatology/kew313. Epub 2016 Sep 4.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chung MP, Richardson C, Kirakossian D, et al; International Myositis Assessment; Clinical Studies Group (IMACS) Calcinosis Scientific Interest Group. Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmun Rev. 2020 Jun;19(6):102533. doi: 10.1016/j.autrev.2020.102533. Epub 2020 Mar 28.</mixed-citation><mixed-citation xml:lang="en">Chung MP, Richardson C, Kirakossian D, et al; International Myositis Assessment; Clinical Studies Group (IMACS) Calcinosis Scientific Interest Group. Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmun Rev. 2020 Jun;19(6):102533. doi: 10.1016/j.autrev.2020.102533. Epub 2020 Mar 28.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Freire V, Bazeli R, Elhai M, et al. Hand and wrist involvement in systemic sclerosis: US features. Radiology. 2013 Dec;269(3): 824-30. doi: 10.1148/radiol.13121994. Epub 2013 Oct 28.</mixed-citation><mixed-citation xml:lang="en">Freire V, Bazeli R, Elhai M, et al. Hand and wrist involvement in systemic sclerosis: US features. Radiology. 2013 Dec;269(3): 824-30. doi: 10.1148/radiol.13121994. Epub 2013 Oct 28.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bartoli F, Fiori G, Braschi F, et al. Calcinosis in systemic sclerosis: subsets, distribution and complications. Rheumatology (Oxford). 2016 Sep;55(9):1610-4. doi: 10.1093/rheumatology/kew193. Epub 2016 May 30.</mixed-citation><mixed-citation xml:lang="en">Bartoli F, Fiori G, Braschi F, et al. Calcinosis in systemic sclerosis: subsets, distribution and complications. Rheumatology (Oxford). 2016 Sep;55(9):1610-4. doi: 10.1093/rheumatology/kew193. Epub 2016 May 30.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kodumudi V, Jeha GM, Mydlo N, Kaye AD. Management of cutaneous calciphylaxis. Adv Ther. 2020 Dec;37(12):4797-4807. doi: 10.1007/s12325-020-01504-w</mixed-citation><mixed-citation xml:lang="en">Kodumudi V, Jeha GM, Mydlo N, Kaye AD. Management of cutaneous calciphylaxis. Adv Ther. 2020 Dec;37(12):4797-4807. doi: 10.1007/s12325-020-01504-w</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chang JJ. Calciphylaxis: diagnosis, pathogenesis, and treatment. Adv Skin Wound Care. 2019 May;32(5):205-215. doi: 10.1097/01.ASW.0000554443.14002.13.</mixed-citation><mixed-citation xml:lang="en">Chang JJ. Calciphylaxis: diagnosis, pathogenesis, and treatment. Adv Skin Wound Care. 2019 May;32(5):205-215. doi: 10.1097/01.ASW.0000554443.14002.13.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Balin SJ, Wetter DA, Andersen LK, Davis MD. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009. Arch Dermatol. 2012 Apr; 148(4):455-62. doi: 10.1001/archdermatol.2011.2052. Epub 2011 Dec 19.</mixed-citation><mixed-citation xml:lang="en">Balin SJ, Wetter DA, Andersen LK, Davis MD. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009. Arch Dermatol. 2012 Apr; 148(4):455-62. doi: 10.1001/archdermatol.2011.2052. Epub 2011 Dec 19.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cucchiari D, Torregrosa JV. Calciphylaxis in patients with chronic kidney disease: a disease which is still bewildering and potentially fatal. Nefrologia. 2018 Nov-Dec;38(6): 579-86. doi:10.1016/j.nefroe.2018.09.001</mixed-citation><mixed-citation xml:lang="en">Cucchiari D, Torregrosa JV. Calciphylaxis in patients with chronic kidney disease: a disease which is still bewildering and potentially fatal. Nefrologia. 2018 Nov-Dec;38(6): 579-86. doi:10.1016/j.nefroe.2018.09.001</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal R, Loganathan P, Koontz D, et al. Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab. Rheumatology (Oxford). 2017 Feb;56(2):247-254. doi: 10.1093/rheumatology/kew396. Epub 2016 Nov 11.</mixed-citation><mixed-citation xml:lang="en">Aggarwal R, Loganathan P, Koontz D, et al. Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab. Rheumatology (Oxford). 2017 Feb;56(2):247-254. doi: 10.1093/rheumatology/kew396. Epub 2016 Nov 11.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wendel S, Venhoff N, Frye BC, et al. Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-kinase inhibitor tofacitinib - a report of two cases. J Autoimmun. 2019 Jun;100:131-136. doi: 10.1016/j.jaut.2019.03.003. Epub 2019 Mar 9.</mixed-citation><mixed-citation xml:lang="en">Wendel S, Venhoff N, Frye BC, et al. Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-kinase inhibitor tofacitinib - a report of two cases. J Autoimmun. 2019 Jun;100:131-136. doi: 10.1016/j.jaut.2019.03.003. Epub 2019 Mar 9.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Петухова ВВ, Идрисова РВ, Снегирева ЛС и др. Первичный опухолевый (туморальный) кальциноз — редкое заболевание в практике ревматолога и ортопеда: опыт применения ингибитора интерлейкина-1 в сочетании с хирургической коррекцией. Ортопедия, травматология и восстановительная хирургия детского возраста. 2019;7(3):85-92.</mixed-citation><mixed-citation xml:lang="en">Petukhova VV, Idrisova RV, Snegireva LS, et al. Primary tumor (tumoral) calcification is a rare disease in the practice of a rheumatologist and orthopedist: experience with the use of an interleukin-1 inhibitor in combination with surgical correction. Ortopediya, travmatologiya i vosstanovitel'naya khirurgiya detskogo vozrasta. 2019;7(3):85-92. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Dauchez A, Souffir C, Quartier P, et al. Hyperphosphatemic familial tumoral calcinosis with galnt3 mutation: transient response to anti-interleukin-1 treatments. JBMR Plus. 2019 Mar 6;3(7):e10185. doi: 10.1002/jbm4.10185</mixed-citation><mixed-citation xml:lang="en">Dauchez A, Souffir C, Quartier P, et al. Hyperphosphatemic familial tumoral calcinosis with galnt3 mutation: transient response to anti-interleukin-1 treatments. JBMR Plus. 2019 Mar 6;3(7):e10185. doi: 10.1002/jbm4.10185</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Mandelbrot DA, Santos PW, Burt RK, et al. Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transpl. 2008 Aug; 23(8):2679-2684. doi: 10.1093/ndt/gfn036.</mixed-citation><mixed-citation xml:lang="en">Mandelbrot DA, Santos PW, Burt RK, et al. Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transpl. 2008 Aug; 23(8):2679-2684. doi: 10.1093/ndt/gfn036.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Антелава ОА, Насонов ЕЛ. Современные методы оценки активности и повреждения при идиопатических воспалительных миопатиях. Научно-практическая ревматология. 2007;(1):59-62.</mixed-citation><mixed-citation xml:lang="en">Antelava OA, Nasonov EL. Modern methods for assessing activity and damage in idiopathic inflammatory myopathies. Nauchno-prakticheskaya revmatologiya. 2007;(1):59-62. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Berger RG, Featherstone GL, Raasch RH, et al. Treatment of calcinosis universalis with low-dose warfarin. Am J Med. 1987 Jul;83(1): 72-6. doi: 10.1016/0002-9343(87)90499-2.</mixed-citation><mixed-citation xml:lang="en">Berger RG, Featherstone GL, Raasch RH, et al. Treatment of calcinosis universalis with low-dose warfarin. Am J Med. 1987 Jul;83(1): 72-6. doi: 10.1016/0002-9343(87)90499-2.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Petri M, Orbai AM, Alarcon GS, et al. Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012 Aug;64(8): 2677-86. doi: 10.1002/art.34473.</mixed-citation><mixed-citation xml:lang="en">Petri M, Orbai AM, Alarcon GS, et al. Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012 Aug;64(8): 2677-86. doi: 10.1002/art.34473.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal R, Rider L, Ruperto N, et al. 2016 American College of Rheumatology/ European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and poly-myositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017 May;76(5):792-801. doi: 10.1136/annrheumdis-2017-211400.</mixed-citation><mixed-citation xml:lang="en">Aggarwal R, Rider L, Ruperto N, et al. 2016 American College of Rheumatology/ European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and poly-myositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017 May;76(5):792-801. doi: 10.1136/annrheumdis-2017-211400.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification Criteria For Systemic Sclerosis: an American College of Rheumatology / European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424</mixed-citation><mixed-citation xml:lang="en">Van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification Criteria For Systemic Sclerosis: an American College of Rheumatology / European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Maeseneer M, Stavros K, Kakkos SK, et al. European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024.</mixed-citation><mixed-citation xml:lang="en">Maeseneer M, Stavros K, Kakkos SK, et al. European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Bodoki L, Nagy-Vincze M, Griger Z, et al. Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011.</mixed-citation><mixed-citation xml:lang="en">Bodoki L, Nagy-Vincze M, Griger Z, et al. Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324.</mixed-citation><mixed-citation xml:lang="en">Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Champion RH. Livedo reticularis. A review. Br J Dermatol. 1965 Apr;77:167-79. doi: 10.1111/j.1365-2133.1965.tb14627.x.</mixed-citation><mixed-citation xml:lang="en">Champion RH. Livedo reticularis. A review. Br J Dermatol. 1965 Apr;77:167-79. doi: 10.1111/j.1365-2133.1965.tb14627.x.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: a review of the literature. Indian Dermatol Online J. 2015 Sep-Oct;6(5):315-21. doi: 10.4103/2229-5178.164493.</mixed-citation><mixed-citation xml:lang="en">Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: a review of the literature. Indian Dermatol Online J. 2015 Sep-Oct;6(5):315-21. doi: 10.4103/2229-5178.164493.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Chiriac A, Grosu OM, Terinte C, Pertea M. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment. J Dermatolog Treat. 2020 Aug;31(5):545-548. doi: 10.1080/09546634.2019.1618435.</mixed-citation><mixed-citation xml:lang="en">Chiriac A, Grosu OM, Terinte C, Pertea M. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment. J Dermatolog Treat. 2020 Aug;31(5):545-548. doi: 10.1080/09546634.2019.1618435.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 201 6 Nov;27(11):3421-3429. doi: 10.1681/ASN.2015091065. Epub 2016 Apr 14.</mixed-citation><mixed-citation xml:lang="en">Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 201 6 Nov;27(11):3421-3429. doi: 10.1681/ASN.2015091065. Epub 2016 Apr 14.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Nigwekar SU, Bloch DB, Nazarian RM, et al. Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis. J Am Soc Nephrol. 2017 Jun;28(6): 1717-22. doi: 10.1681/ASN.2016060651.</mixed-citation><mixed-citation xml:lang="en">Nigwekar SU, Bloch DB, Nazarian RM, et al. Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis. J Am Soc Nephrol. 2017 Jun;28(6): 1717-22. doi: 10.1681/ASN.2016060651.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007 Apr;56(4):569-79. doi: 10.1016/j.jaad.2006.08.065. Epub 2006 Dec 1.</mixed-citation><mixed-citation xml:lang="en">Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007 Apr;56(4):569-79. doi: 10.1016/j.jaad.2006.08.065. Epub 2006 Dec 1.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Tintut Y, Patel J, Territo M, et al. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002 Feb 5;105(5):650-655. doi: 10.1161/hc0502.102969.</mixed-citation><mixed-citation xml:lang="en">Tintut Y, Patel J, Territo M, et al. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002 Feb 5;105(5):650-655. doi: 10.1161/hc0502.102969.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Chen NX, O'Neill K, Akl NK, Moe SM. Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun. 2014 Jun 20;449(1): 151-156. doi: 10.1016/j.bbrc.2014.05.005.</mixed-citation><mixed-citation xml:lang="en">Chen NX, O'Neill K, Akl NK, Moe SM. Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun. 2014 Jun 20;449(1): 151-156. doi: 10.1016/j.bbrc.2014.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">El-Azhary RA, Patzelt MT, McBane RD, et al. Calciphylaxis: a disease of pannicular thrombosis. Mayo Clin Proc. 2016 Oct;91(10): 1395-1402. doi: 10.1016/j.mayocp.2016.06.026.</mixed-citation><mixed-citation xml:lang="en">El-Azhary RA, Patzelt MT, McBane RD, et al. Calciphylaxis: a disease of pannicular thrombosis. Mayo Clin Proc. 2016 Oct;91(10): 1395-1402. doi: 10.1016/j.mayocp.2016.06.026.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008 Mar;58(3):458-471. doi: 10.1016/j.jaad.2007.12.006.</mixed-citation><mixed-citation xml:lang="en">Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008 Mar;58(3):458-471. doi: 10.1016/j.jaad.2007.12.006.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang YX, Tang RN, Wang LT, Liu BC. Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease. Cell Prolif. 2021 Mar;54(3):e12980. doi: 10.1111/cpr.12980.</mixed-citation><mixed-citation xml:lang="en">Zhang YX, Tang RN, Wang LT, Liu BC. Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease. Cell Prolif. 2021 Mar;54(3):e12980. doi: 10.1111/cpr.12980.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Noonan J, Grassia G, MacRitchie N, et al. A novel triple-cell two-dimensional model to study immune-vascular interplay in atherosclerosis. Front Immunol. 2019 Apr 24;10:849. doi: 10.3389/fimmu.2019.00849. eCollection 2019.</mixed-citation><mixed-citation xml:lang="en">Noonan J, Grassia G, MacRitchie N, et al. A novel triple-cell two-dimensional model to study immune-vascular interplay in atherosclerosis. Front Immunol. 2019 Apr 24;10:849. doi: 10.3389/fimmu.2019.00849. eCollection 2019.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
